期刊
LABORATORY INVESTIGATION
卷 91, 期 1, 页码 43-53出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/labinvest.2010.141
关键词
allograft rejection; HMGB1; Th17; transplantation
资金
- National Natural Science Foundation of China [30772039]
- NSFC-Guangdong [U0832003]
- Ministry of Science and Technology of China [2007CB512402]
Previously, we reported that extracellular high-mobility group box 1 (HMGB1) functions as an innate alarmin implicated in cardiac allograft acute rejection. We now present evidence suggesting that HMGB1 is pivotal in inducing interleukin-17 (IL-17)-producing alloreactive T cells by stimulating dendritic cells secretion of IL-6. Those IL-17(+) T cells are likely to be the major effector cells responsible for the early stage of cardiac allograft rejection through mediating an influx of neutrophils into allografts, and therefore, blockade of IL-17A significantly prolonged murine cardiac allograft survival. In contrast to the classical model for a dominant role of IFN-gamma(+)-Th1 cells have in acute allograft rejection, our data suggest that IFN-gamma(+)-Th1 cells are responsible for the late stage of graft destruction by inducing monocyte infiltration when IL-17(+) T-cell response recedes. Blockade of HMGB1 significantly decreased splenic alloreactive Th17 cells and IFN-gamma-producing CD8(+) T cells in the recipients, leading to less infiltration of neutrophils along with lower IL-6 and IL-17 expression levels in the grafts as well as prolongation of cardiac allograft survival. Together, these data support a novel model in which HMGB1 induces IL-17-producing alloreactive T cells to mediate early stage of allograft rejection, whereas IFN-g-producing alloreactive Th1 cells provoke graft destruction after Th17 response recedes. Laboratory Investigation (2011) 91, 43-53; doi:10.1038/labinvest.2010.141; published online 16 August 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据